Anti-diabetic medication showed that 30% of all T2D subjects were on oral medication, 8% were on insulin therapy, 21% were on combined medications (oral and insulin), and 48% were on dietary treatment. This evidence concerns the gene INS and type 2 diabetes mellitus.